alternative semaglutide Alternatives for Weight Loss Semaglutide is an alternative version

Data availability Data supporting the findings of this manuscript are available from the corresponding authors upon reasonable request

Given the frequent coexistence of obesity and T2D with cardiovascular disease and chronic kidney disease (CKD), incretin-based therapies (encompassing selective GLP-1 and multi-receptor agonists) have emerged as disease-modifying treatments across the cardiovascularkidneymetabolic (CKM) spectrum

(Mol Med Rep 2015): represin de genes asociados a cncer colorrectal en lneas celulares

Mutations in melanoma such as increases in copy numbers of the chromosome section that carries the Myc gene or changes in the rat sarcoma (RAS)/rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MAPK) pathways due to mutations (36) or enhanced signaling (37) promoted by growth factors also leads to increased activity of the myc pathway, which again promotes uptake of glucose and glycolysis (38)

The upregulation of genes associated with skin abnormalities, neurodevelopmental disruptions, liver dysfunction, and lung pathology suggests that maternal GLP-1 exposure may lead to significant adverse outcomes for offspring health